Latest Event Updates

Gene Therapy Had a Breakthrough 2017—2018 May Be Even Better

Posted on Updated on

The increase in awareness in regards with the benefits of using gene therapy as compared to conventional therapy for the treatment of various diseases and government support to promote gene therapy related research are the major driving factors that are projected to boost the market growth.

Gene-fixing treatments have now cured a number of patients with cancer and rare diseases. Genes are composed of DNA that contains necessary information for making proteins that are vital for the human body to function optimally. Some gene mutations result in these proteins not being made correctly and can lead to genetic disorders. Gene therapy works by repairing, repressing, or replacing dysfunctional genes that cause disease with the aim of reestablishing normal function. Gene therapy is an attractive area for drug development because with the right target and approach, it can address the root cause of a severe disease. For certain disorders where known genetic mutations lead to deficient or non-functional protein production, gene therapy can fix the underlying defect and provide a path to produce the functional protein.

Check out the “Gene Therapy” Research Report and Get the Sample PDF at:  https://tinyurl.com/y77mcfae 

Gene Therapy- AMR

Gene therapy—the idea of modifying a person’s DNA to treat disease—represents a major shift in medicine. Instead of just treating symptoms like the vast majority of drugs on the market, gene therapy aims to correct the underlying genetic cause of a disease. Doctors and scientists hope these treatments will be a one-shot cure.

Last year, we wrote that 2016 was gene therapy’s most promising year. But 2017 proved to be even bigger. Gene therapy had a hell of a 2017. After decades of promises but failed deliveries, last year saw the field hitting a series of astonishing home runs.

The concept of gene therapy is elegant: like computer bugs, faulty letters in the human genome can be edited and replaced with healthy ones.

But despite early enthusiasm, the field has suffered one setback after another. At the turn of the century, the death of an 18-year-old patient with inherited liver disease after an experimental gene therapy treatment put the entire field into a deep freeze.

But no more. Last year marked the birth of gene therapy 2.0, in which the experimental dream finally became a clinical reality. Here’s how the tech grew into its explosive potential—and a sneak peek at what’s on the horizon for 2018.

The global gene therapy market was valued at $584 million in 2016, and is estimated to reach $4,402 million by 2023, registering a CAGR of 33.3% from 2017 to 2023. Due to the high success rate during the preclinical and clinical trial, gene therapy is gaining popularity. There are many techniques used for gene therapy, for example, a procedure where the mutated gene is being replaced with a healthy gene or inactivation of gene whose function is abnormal.

Tumor suppressor and suicide gene therapy are expected to be a lucrative segment for the market players as they are among the fastest growing segment in the gene therapy market. The therapy involves the introduction of new genes into the tumor cells that help destroy the tumor cells without affecting the neighboring healthy cells.

How Does Gene Therapy Work?

Gene therapy is designed to introduce genetic material into cells to compensate for abnormal genes or to make a beneficial protein. If a mutated gene causes a necessary protein to be faulty or missing, gene therapy may be able to introduce a normal copy of the gene to restore the function of the protein.

A quality that is embedded straightforwardly into a cell more often than not does not work. Rather, a bearer called a vector is hereditarily built to convey the quality. Certain infections are frequently utilized as vectors since they can convey the new quality by contaminating the cell. The infections are adjusted so they can’t cause sickness when utilized as a part of individuals. A few kinds of infection, for example, retroviruses, incorporate their hereditary material (counting the new quality) into a chromosome in the human cell. Different infections, for example, adenoviruses, bring their DNA into the core of the phone, however the DNA isn’t incorporated into a chromosome.

The vector can be infused or given intravenously (by IV) specifically into a particular tissue in the body, where it is taken up by singular cells. On the other hand, an example of the patient’s cells can be evacuated and presented to the vector in a research facility setting. The cells containing the vector are then come back to the patient. On the off chance that the treatment is fruitful, the new quality conveyed by the vector will make a working protein.

Specialists must defeat numerous specialized difficulties previously quality treatment will be a reasonable way to deal with treating ailment. For instance, researchers must discover better approaches to convey qualities and target them to specific cells. They should likewise guarantee that new qualities are absolutely controlled by the body.

The key players operating in the global gene therapy market include Novartis, Kite Pharma, Inc., GlaxoSmithKline PLC, Spark Therapeutics Inc., Bluebird bio Inc., Genethon, Transgene SA, Applied Genetic Technologies Corporation, Oxford BioMedica, and NewLink Genetics Corp.

Other prominent players in the value chain include Amgen, Epeius Biotechnologies, Abeona Therapeutics, Sanofi, UniQure, Juno Therapeutics, Adaptimmune, Celgene, and Advantagene.
Do purchase Inquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/2841

Advertisements

Polymerase Chain Reaction Technologies Market Anticipated to Reach $10,776 Million, Globally, by 2023

Posted on Updated on

According to a new report published by Allied Market Research, titled, Polymerase Chain Reaction Market by Technology, Products, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the polymerase chain reaction market accounted for $7,027 million in 2016, and is estimated to reach $10,776 million by 2023, registering a CAGR of 6.2% from 2017 to 2023. North America is the highest contributor in the polymerase chain reaction market; however, Asia-Pacific is expected to witness the highest growth rate.

Access Full Summary at: https://www.alliedmarketresearch.com/polymerase-chain-reaction-market

PCR techniques have the most potential features such as absolute detection and quantification of genetic materials such as DNA and RNA that are increasingly being used in life sciences research and molecular diagnostics. The device can be used quantify and analyze rare alleles and point mutations. Advanced PCR systems are being developed with enhanced capabilities such as broad menu of tests, higher sensitivity, and specificity. Other major advances related with the PCR are shorter PCR cycling time, higher productivity, and automated workflow.

The advancement in the technology of qPCR and dPCR leading to automation, improved accuracy, and enhanced sensitivity majorly drive the market growth. These products provide high level of efficiency and productivity in research and drug discovery and reduce the time required for the novel drug development. In addition, there is increased demand for polymerase chain reaction technologies owing to increase in number of hospitals and research centers. Furthermore, the increase in number of patients suffering from infectious diseases and rise in funding in gene therapy and human genome projects will also help to fuel the growth of the global polymerase chain reaction technologies market. Moreover, there is growth in demand for polymerase chain reaction technologies in the field of life science, clinical diagnostics, and others, which would further drive the market. However, growth of non-validated home brew test and unstable reimbursement policies are projected to hinder the growth of global polymerase chain reaction technologies market.

The real-time PCR segment is the major contributor towards the global PCR market in 2016, due to several factors including increase in use of qPCR in research and medical diagnostics, technological advancements, growing use of robotics for lab automation, and expansion of installation base.

Among the end-users, academic & research institutions occupied the major share of PCR instrument market due to increased test volume of infectious diseases and various types of cancers.

In 2016, North America accounted for maximum contribution to the total revenue generated, owing to the rise in prevalence of infectious diseases and cancer in this region and technological advancement in PCR. However, Asia is projected to grow at the highest CAGR during the forecast period. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities.

Key Findings of the Polymerase Chain Reaction Market:

  • Digital PCR segment is projected to grow at the highest rate during the analysis period.
  • Reagents and consumables segment was the highest revenue-generating segment in 2016, and is expected to continue its dominance in future.
  • North America dominated global polymerase chain reaction technologies market in 2016, and is projected to continue its dominance in future.
  • China is expected to grow highest in the Asia-Pacific region during the forecast period.
  • Services segment was the largest contributor among the products and services segments.

Shoulder Arthroplasty Market Expected to reach $1,814 Million, Globally, by 2023

Posted on Updated on

Summary: “Shoulder Arthroplasty Market” includes Market Size, Share, Trends, Growth, Demand, Supply, Application, production, capacity utilization, supply, Analysis and Forecast

Shoulder replacement or shoulder arthroplasty procedures are performed to replace the ball and sometimes the socket using a prosthesis made up of polythene and metal components. Several types of shoulder arthroplasties can be performed such as partial shoulder arthroplasty, total shoulder arthroplasty, and revision shoulder arthroplasty, depending on the severity of the shoulder joint damage.

Get Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/2599

Increase in incidence of arthritis and surge in in geriatric population drive the growth of the global shoulder arthroplasty market. In addition, rise in focus of manufacturers on developing advanced shoulder fracture repair devices supplements the market growth. However, increase in risk of postoperative injuries associated with shoulder arthroplasties hampers the market growth. Conversely, surge in investment by manufacturers to develop shoulder arthroplasty devices in the emerging economies and rise in initiatives to increase awareness towards available treatments for shoulder injuries are expected to provide profitable opportunities for market expansion.

The shoulder arthroplasty platform systems segment is expected to witness a growth rate of 8.4% from 2017 to 2023, owing to high investments by the key players in developing shoulder replacement platform systems such as GLOBAL UNITE Platform Shoulder System and Exactech shoulder system. The arthritis indication segment accounted for approximately half of the total market share in 2016, and is anticipated to continue its dominance throughout the forecast period. This is attributed to increase in incidence of various forms of arthritis such as osteoarthritis, rheumatoid arthritis, and other inflammatory arthritis.

The hospitals & clinics segment generated the highest revenue in 2016, accounting for two-thirds of the total market share, and is projected to maintain this trend throughout the forecast period. Moreover, outpatient surgical centers segment is expected to witness high growth rate of 9.0%, due to increase in number of shoulder arthroplasties being carried out in outpatient surgical facilities, as they are considered to be as safe as inpatient shoulder arthroplasty surgeries.

View Detail Summary of this report: https://www.alliedmarketresearch.com/shoulder-arthroplasty-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Implantable Medical Devices Market Is Expected to Reach $116,300 Million by 2022, Globally – Allied Market Research

Posted on

The implantable medical devices market is driven by factors such as increase in geriatric population, rapid technological advancements, growth in incidence of chronic diseases, and upsurge in adoption of advanced implantable medical devices. However, high cost of implantable medical devices and limited coverage of insurance schemes hamper the market growth. The implantable medical devices market has attained maturity in the developed region. However, increase in awareness for implants among individuals has supplemented the market growth in the emerging economies.

Get Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/492

Cardiovascular implants market is expected grow with a CAGR of 6.5% from 2016 to 2022. This is due to the rising prevalence of cardiovascular disorders (CVD), technological innovations, increasing geriatric population and favorable reimbursement policies by government and healthcare agencies. The other implants segment is expected to register the fastest CAGR of 10.6% during the forecast period, due to increase in prevalence of neurological diseases, craniomaxillofacial deformities, and eye disorders, and preference for cosmetic surgeries.

The North American implantable medical devices market contributed the highest revenue to the global market in 2015, accounting for nearly half of the market share. The U.S. was the major contributor to the revenue of the North American market due to growing awareness about the use of medical implants and high prevalence of chronic diseases in the region. Although the market has attained maturity due to the widespread adoption of these devices over the past few years, the introduction of technologically advanced devices is expected to provide ample scope for the market growth.

Access Full Summary at:
https://www.alliedmarketresearch.com/implantable-medical-devices-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Cataract Surgery Devices Market Size & Share Set For Accelerated Growth By 2023

Posted on Updated on

Summary: “Cataract Surgery Devices Market” includes Market Size, Share, Trends, Growth, Demand, Supply, Application, production, capacity utilization, supply, Analysis and Forecast

Cataract Surgery Devices Market by Product, Type, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the cataract surgery devices market was valued at $7,025 million in 2016, and is projected to reach $9,587 million by 2023, growing at a CAGR of 4.3% from 2017 to 2023. The intraocular lenses (IOLs) segment accounted for half share of the global market in 2016.

Get Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/2609

Cataract is a condition in which clouding of the lens occurs. Cataract surgery devices are instruments and consumables, such as intraocular lens (IOLs), salt solutions, forceps, syringe, liquids for scrubbing, and various hand pieces, which aid in a cataract surgery. These surgery devices help enter vitreous cavity and separating the natural lens from the cavity.

Increase in incidences of diseases such as diabetes, obesity, and hypertension. In addition, the growth in geriatric population also boosts the growth of the market as geriatric population is more prone to cataract ailments. However, dearth of skilled professionals restrain the growth of the market. Moreover, government and non-profit organizations introduce programs to reduce the burden of cataract-related diseases globally, which create lucrative opportunities for key market players.

The consumables segment generated the highest revenue in 2016 accounting for two-thirds share of the global market, and is anticipated to dominate the market throughout the forecast period. This is attributed to the increase in demand for cataract surgeries, which in turn boost the growth of the consumables segment.

The ophthalmology clinics segment accounted for the three-eighths share of the global market in 2016, and is expected to register the highest CAGR of 4.7% during the forecast period. This is attributed to the increase in awareness among individual due to the various camps and activities conducted by ophthalmology clinics. In addition, ophthalmology clinics also has a vast range of cataract surgical equipment, which are mostly scarce in hospital settings.

Asia-Pacific witnessed the highest growth rate in the global market from 2017 to 2023. This is attributed to growth in awareness related to cataract as well as due to the introduction of novel cataract surgery procedures. For instance, in 2012 bladeless cataract surgery was introduced in India. However, laser-assisted cataract surgery was not widely accepted at the beginning, nevertheless after the introduction of many reimbursement schemes by the government and increase in awareness, laser-assisted cataract surgeries are accepted widely in the Asia-Pacific.

View Detail Summary of this report: https://www.alliedmarketresearch.com/cataract-surgery-device-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Liqueurs Market Key Strategic Moves and Developments

Posted on Updated on

Summary: According to a new report published by Allied Market Research titled, Liqueurs Market by Type and Distribution channel: Global Opportunity Analysis and Industry Forecast, 2017-2023, the liqueurs market was valued at $111 billion in 2016, and is projected to reach $131 billion by 2023, growing at a CAGR of 2.5% from 2017 to 2023.

Liqueur is an alcoholic beverage, commonly flavored or sweetened to provide a new texture for the drink. These beverages are divided into three general classesneutrals/bitters, creams, and fruit flavored. Liqueurs are generally made with neutral grain spirits, referring to the flavor being neutral, as the spirits are not finished. The demand for these beverages has changed in the last few years, considering the on/off premises consumption trends.

Get Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/3468

Increase in global young adult demographic coupled with high disposable income fuel the global liqueurs market. However, lack of penetration in the emerging countries, and escalation of sport drink market, owing to health concerns is expected to restrict the market growth in the future. Introduction of healthier varieties of beer and spirits is expected to offer lucrative opportunities for market players.

Bitters is expected to maintain its dominance in the market during the forecast period. This segment held close to two-fifths of the market share in 2016, in value terms, owing to established demand and blend readiness. However, creams are expected to grow with a faster rate due high demand from mixologists and younger demographic during the forecast period.

In 2016, retail distribution channels dominated the global market, with nearly one-third share, in terms of volume. Increase in demand for off premises consumption owing to promotion campaigns is anticipated to drive the market growth.

Access Full Summary at: https://www.alliedmarketresearch.com/liqueurs-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Soy Protein Ingredients Market Raw Material and Suppliers

Posted on Updated on

Summary: The soy protein ingredients market was valued at $7,506 million in 2016, and is projected to reach at $12,205 million by 2023, registering a CAGR of 7.2% from 2017 to 2023.

Soy proteins are derived from soybean meal, which has been defatted & dehulled. Defatted & dehulled soybeans are processed into three types of high-protein commercial products, namely, soy protein concentrates, soy protein isolates, and soy flours.

Get Sample Copy of Report: https://www.alliedmarketresearch.com/request-sample/1994

Currently, the global soy protein ingredients market is witnessing numerous opportunities due to increase in awareness among consumers for protein healthy diet. Moreover, soy protein concentrate is a nutritional supplement manufactured after the soy is dehulled & defatted. Soy protein concentrate is obtained upon the removal of certain percentage of non-protein constituents from the raw soymeal. The percentage of protein in lower end concentrates ranges from 30% to 90%. In addition, consumption of soy protein concentrate powder as a supplement has increased, owing to regular recommendations by dieticians & doctors in response to a wider set of customers demand for protein supplements in their diets. Rise in prevalence of alternatives, such as whey protein ingredients and increase in inclination of consumers toward high-quality animal protein are some factors anticipated to hamper the market growth.

The functional foods segment accounted for around one-fifth share, in terms of volume, in 2016. In response to the perennial modifications, such as brining, baking, and texture of soy products among the bakery & confectionery industry and meat alternatives, soy protein ingredients are in high demand globally. Thus, increase in demand for soy protein concentrates, especially in sports nutrition as protein supplements, fuels the market growth.

Access Full Summary at: https://www.alliedmarketresearch.com/soy-protein-ingredients-market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.